Literature DB >> 1914498

Purification of the isoforms of tear specific prealbumin.

R J Fullard1, D M Kissner.   

Abstract

A chromatographic method for separating tear specific prealbumin (TSP) into six isoelectric forms is described. Size exclusion high performance liquid chromatography (SE-HPLC) was used to isolate TSP from whole tears, followed by chromatofocusing fast protein liquid chromatography (FPLC) of the SE-TSP fraction on a Mono P column. This yielded six fractions varying in isoelectric point (pI) between 5.3 and 4.6. Subsequent anion exchange FPLC (Mono Q column) allowed a slight further purification of each Mono P fraction and removed Polybuffer from the Mono P fractions. Isoelectric focusing (IEF) of the TSP isoforms verified that the heterogeneity was based on pI, and confirmed that the chromatofocusing separation was in many respects the same as an IEF separation. Purity of TSP isoforms was determined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), IEF, enzyme-linked immunosorbent assay (ELISA) and immunoblotting of samples separated by SDS-PAGE and IEF. Amino acid analysis and N-terminal amino acid sequencing revealed subtle differences between the TSP isoforms. The entire purification procedure was conducted both with and without the addition of reducing agents and protease inhibitors to tear samples and all buffers used in the purification process. Relatively little difference was seen in the TSP isoform profile under these two sets of conditions. However, the tendency of isolated TSP to aggregate and precipitate was dramatically decreased under reducing conditions, resulting in significantly higher protein recoveries. This chromatographic purification procedure provides a basis for further study of the nature of the heterogeneity of TSP and characterization of the properties of this protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914498     DOI: 10.3109/02713689109013853

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  10 in total

1.  A bead-based fluorescence immunosensing technique enabled by the integration of Förster resonance energy transfer and optoelectrokinetic concentration.

Authors:  Jhih-Cheng Wang; Hu-Yao Ku; Dar-Bin Shieh; Han-Sheng Chuang
Journal:  Biomicrofluidics       Date:  2016-01-28       Impact factor: 2.800

2.  Decreased tear lipocalin concentration in patients with meibomian gland dysfunction.

Authors:  M Yamada; H Mochizuki; M Kawai; K Tsubota; T J Bryce
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 3.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

4.  Gene expression in human accessory lacrimal glands of Wolfring.

Authors:  John L Ubels; Ilene K Gipson; Sandra J Spurr-Michaud; Ann S Tisdale; Rachel E Van Dyken; Mark P Hatton
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

5.  Tear lipocalin: evidence for a scavenging function to remove lipids from the human corneal surface.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Pawan Prasher; Taleh N Yusifov; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

6.  Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores.

Authors:  Maria Fluckinger; Hubertus Haas; Petra Merschak; Ben J Glasgow; Bernhard Redl
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme.

Authors:  B J Glasgow
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

8.  Adsorption of human tear lipocalin to human meibomian lipid films.

Authors:  Thomas J Millar; Poonam Mudgil; Igor A Butovich; Chendur K Palaniappan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-29       Impact factor: 4.799

9.  Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum.

Authors:  Sixto M Leal; Sanhita Roy; Chairut Vareechon; Steven deJesus Carrion; Heather Clark; Manuel S Lopez-Berges; Antonio Di Pietro; Antonio diPietro; Marcus Schrettl; Nicola Beckmann; Bernhard Redl; Hubertus Haas; Eric Pearlman
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

10.  Tear Lipocalin and Lipocalin-Interacting Membrane Receptor.

Authors:  Ben J Glasgow
Journal:  Front Physiol       Date:  2021-08-19       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.